Ioannis Kourtzelis

Ioannis Kourtzelis

Auto-generated profile, based on publicly available information

Ioannis Kourtzelis

Hull York Medical School, University of York

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell
Verified
Journal Article
Open access
IMIoannis Mitroulis
Ioannis Mitroulis
KRKlara Ruppova
Klara Ruppova
BWBaomei Wang
Baomei Wang
LCLan-Sun Chen
Lan-Sun Chen
MGMichal Grzybek
Michal Grzybek
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Trained innate immunity fosters a sustained favorable response of myeloid cells to a secondary challenge, despite their short lifespan in circulation. We thus hypothesized that trained immunity acts via modulation of hematopoietic stem and progenitor cells (HSPCs). Administration of β-glucan (prototypical trained-immunity-inducing agonist) to mice induced expansion of progenitors of the myeloid lineage, which was associated with elevated signaling by innate immune mediators, such as IL-1β and granulocyte-macrophage colony-stimulating factor (GM-CSF), and with adaptations in glucose metabolism and cholesterol biosynthesis. The trained-immunity-related increase in myelopoiesis resulted in a beneficial response to secondary LPS challenge and protection from chemotherapy-induced myelosuppression in mice. Therefore, modulation of myeloid progenitors in the bone marrow is an integral component of trained immunity, which to date, was considered to involve functional changes of mature myeloid cells in the periphery.

1 January 2018 in Cell
Verified
Journal Article
Closed access
SBSiroon Bekkering
Siroon Bekkering
RARob J.W. Arts
Rob J.W. Arts
BNBoris Novakovic
Boris Novakovic
IKIoannis Kourtzelis
Ioannis Kourtzelis
CHCharlotte D.C.C. van der Heijden
Charlotte D.C.C. van der Heijden
MNMihai G. Netea
Mihai G. Netea

1 October 2020 in Cell
Verified
Journal Article
Open access
LKLydia Kalafati
Lydia Kalafati
IKIoannis Kourtzelis
Ioannis Kourtzelis
JSJonas Schulte-Schrepping
Jonas Schulte-Schrepping
XLXiaofei Li
Xiaofei Li
AHAikaterini Hatzioannou
Aikaterini Hatzioannou
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Trained innate immunity, induced via modulation of mature myeloid cells or their bone marrow progenitors, mediates sustained increased responsiveness to secondary challenges. Here, we investigated whether anti-tumor immunity can be enhanced through induction of trained immunity. Pre-treatment of mice with β-glucan, a fungal-derived prototypical agonist of trained immunity, resulted in diminished tumor growth. The anti-tumor effect of β-glucan-induced trained immunity was associated with transcriptomic and epigenetic rewiring of granulopoiesis and neutrophil reprogramming toward an anti-tumor phenotype; this process required type I interferon signaling irrespective of adaptive immunity in the host. Adoptive transfer of neutrophils from β-glucan-trained mice to naive recipients suppressed tumor growth in the latter in a ROS-dependent manner. Moreover, the anti-tumor effect of β-glucan-induced trained granulopoiesis was transmissible by bone marrow transplantation to recipient naive mice. Our findings identify a novel and therapeutically relevant anti-tumor facet of trained immunity involving appropriate rewiring of granulopoiesis.

16 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IMIoannis Mitroulis
Ioannis Mitroulis
KKKonstantinos Kambas
Konstantinos Kambas
ACAkrivi Chrysanthopoulou
Akrivi Chrysanthopoulou
PSPanagiotis Skendros
Panagiotis Skendros
EAEirini Apostolidou
Eirini Apostolidou
KRKonstantinos Ritis
Konstantinos Ritis
Gout is a prevalent inflammatory arthritis affecting 1–2% of adults characterized by activation of innate immune cells by monosodium urate (MSU) crystals resulting in the secretion of interleukin-1β (IL-1β). Since neutrophils play a major role in gout we sought to determine whether their activation may involve the formation of proinflammatory neutrophil extracellular traps (NETs) in relation to autophagy and IL-1β. Synovial fluid neutrophils from six patients with gout crisis and peripheral blood neutrophils from six patients with acute gout and six control subjects were isolated. MSU crystals, as well as synovial fluid or serum obtained from patients with acute gout, were used for the treatment of control neutrophils. NET formation was assessed using immunofluorescence microscopy. MSU crystals or synovial fluid or serum from patients induced NET formation in control neutrophils. Importantly, NET production was observed in neutrophils isolated from synovial fluid or peripheral blood from patients with acute gout. NETs contained the alarmin high mobility group box 1 (HMGB1) supporting their pro-inflammatory potential. Inhibition of phosphatidylinositol 3-kinase signaling or phagolysosomal fusion prevented NET formation, implicating autophagy in this process. NET formation was driven at least in part by IL-1β as demonstrated by experiments involving IL-1β and its inhibitor anakinra. These findings document for the first time that activation of neutrophils in gout is associated with the formation of proinflammatory NETs and links this process to both autophagy and IL-1β. Modulation of the autophagic machinery may represent an additional therapeutic study in crystalline arthritides.

31 March 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
IKIoannis Kourtzelis
Ioannis Kourtzelis
GHGeorge Hajishengallis
George Hajishengallis
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Efficient inflammation resolution is important not only for the termination of the inflammatory response but also for the restoration of tissue integrity. An integral process to resolution of inflammation is the phagocytosis of dying cells by macrophages, known as efferocytosis. This function is mediated by a complex and well-orchestrated network of interactions amongst specialized phagocytic receptors, bridging molecules, as well as “find-me” and “eat-me” signals. Efferocytosis serves not only as a waste disposal mechanism (clearance of the apoptotic cells) but also promotes a pro-resolving phenotype in efferocytic macrophages and thereby termination of inflammation. Alterations in cellular metabolism are critical for shaping the phenotype and function of efferocytic macrophages, thus, representing an important determinant of macrophage plasticity. Impaired efferocytosis can result in inflammation-associated pathologies or autoimmunity. The present mini review summarizes current knowledge regarding the mechanisms regulating macrophage efferocytosis during clearance of inflammation.

19 November 2018 in Nature Immunology
Verified
Journal Article
Closed access
IKIoannis Kourtzelis
Ioannis Kourtzelis
XLXiaofei Li
Xiaofei Li
IMIoannis Mitroulis
Ioannis Mitroulis
DGDaniel Grosser
Daniel Grosser
TKTetsuhiro Kajikawa
Tetsuhiro Kajikawa
TCTriantafyllos Chavakis
Triantafyllos Chavakis